Summary
Regeneron Pharmaceuticals, Inc. filed a Current Report on Form 8-K on January 24, 2001, to announce its operating results for the fourth quarter and the full year ended December 31, 2000. The report primarily serves to attach the press release containing these financial and operational updates. Investors would look to this filing for the company's performance metrics as of the end of the fiscal year 2000.
Key Highlights
- 1Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on January 24, 2001.
- 2The filing's primary purpose was to announce the company's operating results.
- 3The results covered the fourth quarter and the full fiscal year ended December 31, 2000.
- 4Exhibit 99.1, a press release dated January 25, 2001, contains the detailed operating results.
- 5This filing provides an update on the company's financial performance at the close of the year 2000.
- 6The report does not contain any other material events or financial statements beyond the press release.